Case number 2019-2050
Dana-Farber Cancer Institute v. Ono Pharmaceutical Co., Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | DANA-FARBER CANCER INSTITUTE v. ONO PHARMACEUTICAL CO., LTD. [OPINION] [precedential] (0) |
| Oct 23, 2020 | 60 | Mandate issued to the United States District Court for the District of Massachusetts. Service as of this date by the Clerk of Court. [731025] [JAB] [Entered: 10/23/2020 11:06 AM] (1) |
| Oct 16, 2020 | 59 | ORDER filed denying [54] petition for panel rehearing, for en banc rehearing filed by Bristol-Myers Squibb Company, Ono Pharmaceutical Co., Ltd., Tasuku Honjo and E.R. Squibb & Sons, L.L.C. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [729250] [JAB] [Entered: 10/16/2020 09:02 AM] (2) |
| Oct 5, 2020 | 58 | Notice from Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. of Withdrawal of Counsel. Service: 10/05/2020 by email. [726545] [19-2050] [Matthew Tymann] [Entered: 10/05/2020 01:59 PM] (2) |
| Sep 15, 2020 | 57 | 18 paper copies of Doc. No. [56] received from Dana-Farber Cancer Institute, Inc. [724359] [MJL] [Entered: 09/24/2020 05:13 PM] (0) |
| Sep 14, 2020 | 56 | RESPONSE of Appellee Dana-Farber Cancer Institute, Inc. to the petition [54], petition [54]. Service: 09/14/2020 by email. [721357] [19-2050] [Donald Ware] [Entered: 09/14/2020 02:48 PM] (24) |
| Aug 31, 2020 | 55 | The court invites a response from Dana-Farber Cancer Institute, Inc. to the combined petition for panel rehearing and rehearing en banc [54] filed by Appellants in 19-2050. Response due 09/14/2020. Service as of this date by the Clerk of Court. [718429] [MJL] [Entered: 08/31/2020 09:40 AM] (1) |
| Aug 27, 2020 | 54 | Petition for panel rehearing, for en banc rehearing filed by Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 08/27/2020 by email. [718023] [19-2050] [Seth Waxman] [Entered: 08/27/2020 01:45 PM] (42) |
| Aug 4, 2020 | 53 | ORDER filed. The motion [51] is granted to the extent that the petition is due on or before August 27, 2020. No further extensions of time should be expected. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [712359] [JAB] [Entered: 08/04/2020 12:24 PM] (2) |
| Aug 3, 2020 | 52 | RESPONSE of Appellee Dana-Farber Cancer Institute, Inc. to the motion to extend time to file petition for rehearing/en banc [51] filed by Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 08/03/2020 by email. [712080] [19-2050] [Donald Ware] [Entered: 08/03/2020 04:58 PM] (7) |
| Aug 3, 2020 | 51 | MOTION of Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 09/10/2020 [Consent: opposed]. Service: 08/03/2020 by email. [711902] [19-2050] [Seth Waxman] [Entered: 08/03/2020 12:57 PM] (10) |
| Jul 14, 2020 | 50 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [707277] [JAB] [Entered: 07/14/2020 09:31 AM] (1) |
| Jul 14, 2020 | 49 | OPINION filed for the court by Newman, Circuit Judge; Lourie, Circuit Judge and Stoll, Circuit Judge. Precedential Opinion. [707276] [JAB] [Entered: 07/14/2020 09:30 AM] (16) |
| May 8, 2020 | 48 | Submitted after ORAL ARGUMENT by Mr. Seth P. Waxman for Bristol-Myers Squibb Company, Ono Pharmaceutical Co., Ltd., Tasuku Honjo and E.R. Squibb & Sons, L.L.C. and Mr. Donald Ross Ware, Esq. for Dana-Farber Cancer Institute, Inc. Panel: Judge: Newman , Judge: Lourie , Judge: Stoll. [693097] [JCP] [Entered: 05/08/2020 11:12 AM] (0) |
| Apr 21, 2020 | 47 | Clerk's Letter to Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd. and Appellee Dana-Farber Cancer Institute, Inc. (May 2020 Telephonic Argument Orientation). Service as of this date by the Clerk of Court. [688906] [JBP] [Entered: 04/21/2020 04:32 PM] (0) |
| Apr 13, 2020 | 46 | ORDER filed. The court will conduct argument in this case by telephone at the originally scheduled date and time in lieu of in-person appearance. The Clerk's Office will provide additional instructions to counsel at least one week ahead of time. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [686537] [MJL] [Entered: 04/13/2020 04:45 PM] (2) |
| Apr 13, 2020 | 45 | Response to notice of oral argument from the Appellee Dana-Farber Cancer Institute, Inc.. [686350] [19-2050] [Donald Ware] [Entered: 04/13/2020 12:22 PM] (3) |
| Apr 10, 2020 | 44 | Response to notice of oral argument from the Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. [686164] [19-2050] [Seth Waxman] [Entered: 04/10/2020 08:20 PM] (3) |
| Mar 20, 2020 | 43 | NOTICE OF ORAL ARGUMENT. Panel: 2005M. Case scheduled May 8, 2020 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 04/15/2020. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [680526] [JAB] [Entered: 03/20/2020 12:45 PM] (2) |
| Feb 14, 2020 | 42 | The following conflict dates submitted by Attorney Seth P. Waxman for Appellants Bristol-Myers Squibb Company, Ono Pharmaceutical Co., Ltd., Tasuku Honjo and E.R. Squibb & Sons, L.L.C. have been accepted by the court: 04/08/2020, 04/09/2020, 04/10/2020, 08/31/2020, 09/01/2020, 09/02/2020, 09/03/2020, 09/04/2020. [671276] [JAB] [Entered: 02/14/2020 08:19 AM] (0) |
| Feb 13, 2020 | 41 | Notice from Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. regarding conflicts with oral argument. Service: 02/13/2020 by email. [671231] [19-2050] [Seth Waxman] [Entered: 02/13/2020 07:31 PM] (4) |
| Feb 13, 2020 | 40 | Notice from Appellee Dana-Farber Cancer Institute, Inc. regarding conflicts with oral argument. Service: 02/13/2020 by email. [671209] [19-2050] [Donald Ware] [Entered: 02/13/2020 05:58 PM] (3) |
| Feb 11, 2020 | 39 | 6 paper copies of the Confidential Appendix (Vol. I - III) [30] received from Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. [670810] [CJF] [Entered: 02/12/2020 02:50 PM] (0) |
| Feb 11, 2020 | 38 | 6 paper copies of the Reply Brief [29] received from Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. [670807] [CJF] [Entered: 02/12/2020 02:49 PM] (0) |
| Feb 11, 2020 | 37 | 6 paper copies of the Opening Brief [22] received from Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. [670806] [CJF] [Entered: 02/12/2020 02:48 PM] (0) |
| Feb 10, 2020 | 36 | 6 paper copies of the Confidential Opening Response Brief [25] received from Appellee Dana-Farber Cancer Institute, Inc. [669743] [CJF] [Entered: 02/10/2020 11:27 AM] (0) |
| Feb 6, 2020 | 35 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [669184] [MMA] [Entered: 02/06/2020 06:23 PM] (1) |
| Feb 6, 2020 | 34 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [669183] [MMA] [Entered: 02/06/2020 06:22 PM] (0) |
| Jan 21, 2020 | 31 | MODIFIED ENTRY: APPENDIX FILED for Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. Number of Pages: 1583. Service: 01/21/2020 by email. [664777]--[Edited 02/06/2020 by MMA - Reason: compliance review complete] [Seth Waxman] [Entered: 01/21/2020 03:49 PM] (1583) |
| Jan 21, 2020 | 30 | MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED for Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. Number of Pages: 1583. Service: 01/21/2020 by email. [664765]--[Edited 02/06/2020 by MMA - Reason: compliance review complete] [Seth Waxman] [Entered: 01/21/2020 03:43 PM] (0) |
| Jan 21, 2020 | 32 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 01/21/2020 by email. [664784] [19-2050] [Seth Waxman] [Entered: 01/21/2020 03:53 PM] (6) |
| Jan 21, 2020 | 33 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd. and Appellee Dana-Farber Cancer Institute, Inc.. Service: 01/21/2020 by email. [664785] [19-2050] [Seth Waxman] [Entered: 01/21/2020 03:54 PM] (4) |
| Jan 14, 2020 | 29 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. Number of Pages: 31. Service: 01/14/2020 by email. [662978]--[Edited 02/06/2020 by MMA - Reason: compliance review complete] [Seth Waxman] [Entered: 01/14/2020 04:41 PM] (41) |
| Dec 23, 2019 | 28 | **TEXT ONLY** ORDER granting motion to extend time to file brief [27] filed by Appellants Bristol-Myers Squibb Company, Ono Pharmaceutical Co., Ltd., Tasuku Honjo and E.R. Squibb & Sons, L.L.C.. The reply brief is due 01/14/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [658676] [MMA] [Entered: 12/23/2019 06:15 PM] (0) |
| Dec 18, 2019 | 27 | MOTION of Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. to extend the time to 01/14/2020 to file the Reply Brief. [Consent: unopposed]. Service: 12/18/2019 by email. [657391] [19-2050] [Seth Waxman] [Entered: 12/18/2019 09:02 AM] (6) |
| Dec 10, 2019 | 26 | MODIFIED ENTRY: BRIEF FILED for Appellee Dana-Farber Cancer Institute, Inc. Number of Pages: 62. Service: 12/10/2019 by email. [655452]--[Edited 01/08/2020 by MMA - Reason: compliance review complete] [Donald Ware] [Entered: 12/10/2019 11:26 PM] (73) |
| Dec 10, 2019 | 25 | MODIFIED ENTRY: CONFIDENTIAL BRIEF FILED for Appellee Dana-Farber Cancer Institute, Inc. Number of Pages: 62. Service: 12/10/2019 by email. [655451]--[Edited 01/08/2020 by MMA - Reason: compliance review complete] [Donald Ware] [Entered: 12/10/2019 11:22 PM] (0) |
| Oct 31, 2019 | 24 | **TEXT ONLY** ORDER granting motion to extend time to file brief [23] filed by Appellee Dana-Farber Cancer Institute, Inc. The response brief is due 12/10/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [646131] [MMA] [Entered: 10/31/2019 12:02 PM] (0) |
| Oct 28, 2019 | 23 | MOTION of Appellee Dana-Farber Cancer Institute, Inc. to extend the time to 12/10/2019 to file the Brief of Appellee. [Consent: unopposed]. Service: 10/28/2019 by email. [645281] [19-2050] [Donald Ware] [Entered: 10/28/2019 05:05 PM] (10) |
| Sep 30, 2019 | 22 | MODIFIED ENTRY: BRIEF FILED for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. Number of Pages: 63. Service: 09/30/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [639099]--[Edited 10/16/2019 by MMA - Reason: compliance review complete] [Seth Waxman] [Entered: 09/30/2019 02:05 PM] (411) |
| Sep 11, 2019 | 21 | **TEXT ONLY** ORDER granting motion to extend time to file brief [19] filed by Appellants Bristol-Myers Squibb Company, Ono Pharmaceutical Co., Ltd., Tasuku Honjo and E.R. Squibb & Sons, L.L.C. The opening brief is due 09/30/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [634830] [MMA] [Entered: 09/11/2019 04:45 PM] (0) |
| Sep 9, 2019 | 20 | Notice of Correction to Doc No. [18] for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 09/09/2019 by email. [633961] [19-2050] [Seth Waxman] [Entered: 09/09/2019 11:11 AM] (5) |
| Sep 9, 2019 | 19 | MOTION of Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. to extend the time to 09/30/2019 to file the Principal Brief. [Consent: unopposed]. Service: 09/09/2019 by email. [633890] [19-2050] [Seth Waxman] [Entered: 09/09/2019 09:02 AM] (6) |
| Sep 9, 2019 | 18 | MOTION of Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. to extend the time to 09/30/2019 to file the Reply Brief. [Consent: unopposed]. Service: 09/09/2019 by email. [633878] [19-2050] [Seth Waxman] [Entered: 09/09/2019 08:50 AM] (6) |
| Jul 22, 2019 | 17 | **TEXT ONLY** ORDER granting motion to extend time to file brief [16] filed by Appellants Bristol-Myers Squibb Company, Ono Pharmaceutical Co., Ltd., Tasuku Honjo and E.R. Squibb & Sons, L.L.C. Appellant's brief is due 09/16/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [622525] [MMA] [Entered: 07/22/2019 01:59 PM] (0) |
| Jul 22, 2019 | 16 | MOTION of Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. to extend the time to 09/16/2019 to file the Principal Brief. [Consent: unopposed]. Service: 07/22/2019 by email. [622476] [19-2050] [Seth Waxman] [Entered: 07/22/2019 12:01 PM] (9) |
| Jul 3, 2019 | 15 | Docketing Statement for the Appellee Dana-Farber Cancer Institute, Inc.. Service: 07/03/2019 by email. [618903] [19-2050] [Donald Ware] [Entered: 07/03/2019 12:36 PM] (4) |
| Jul 3, 2019 | 14 | Certificate of Interest for Appellee Dana-Farber Cancer Institute, Inc.. Service: 07/03/2019 by email. [618902] [19-2050] [Donald Ware] [Entered: 07/03/2019 12:32 PM] (3) |
| Jul 3, 2019 | 13 | Entry of appearance for Matthew A. Pearson as of counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618839] [19-2050] [Dianne Elderkin] [Entered: 07/03/2019 10:43 AM] (2) |
| Jul 3, 2019 | 12 | Entry of appearance for Steven D. Maslowski as of counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618835] [19-2050] [Dianne Elderkin] [Entered: 07/03/2019 10:41 AM] (2) |
| Jul 3, 2019 | 11 | Entry of appearance for Dianne B. Elderkin as of counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618832] [19-2050] [Dianne Elderkin] [Entered: 07/03/2019 10:38 AM] (2) |
| Jul 3, 2019 | 10 | Docketing Statement for the Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618808] [19-2050] [Seth Waxman] [Entered: 07/03/2019 09:51 AM] (4) |
| Jul 3, 2019 | 9 | Certificate of Interest for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618806] [19-2050] [Seth Waxman] [Entered: 07/03/2019 09:50 AM] (3) |
| Jul 3, 2019 | 8 | Entry of appearance for Matthew C. Tymann as of counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618804] [19-2050] [Matthew Tymann] [Entered: 07/03/2019 09:48 AM] (2) |
| Jul 3, 2019 | 7 | Entry of appearance for Steven J. Horn as of counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618802] [19-2050] [Steven Horn] [Entered: 07/03/2019 09:46 AM] (2) |
| Jul 3, 2019 | 6 | Entry of appearance for Thomas G. Saunders as of counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618800] [19-2050] [Thomas Saunders] [Entered: 07/03/2019 09:44 AM] (2) |
| Jul 3, 2019 | 5 | Entry of appearance for Seth P. Waxman as principal counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618798] [19-2050] [Seth Waxman] [Entered: 07/03/2019 09:42 AM] (2) |
| Jul 2, 2019 | 4 | Entry of appearance for Sarah S. Burg as of counsel for Appellee Dana-Farber Cancer Institute, Inc.. Service: 07/02/2019 by email. [618705] [19-2050] [Sarah Burg] [Entered: 07/02/2019 04:52 PM] (2) |
| Jul 2, 2019 | 3 | Entry of appearance for Donald R. Ware as principal counsel for Appellee Dana-Farber Cancer Institute, Inc.. Service: 07/02/2019 by email. [618704] [19-2050] [Donald Ware] [Entered: 07/02/2019 04:48 PM] (2) |
| Jul 2, 2019 | 2 | Entry of appearance for Barbara A. Fiacco as of counsel for Appellee Dana-Farber Cancer Institute, Inc.. Service: 07/02/2019 by email. [618700] [19-2050] [Barbara Fiacco] [Entered: 07/02/2019 04:38 PM] (2) |
| Jun 19, 2019 | 1 | Appeal docketed. Received: 06/18/2019. [615411]Entry of Appearance due 07/03/2019. Certificate of Interest is due on 07/03/2019. Docketing Statement due 07/03/2019. Appellant's brief is due 08/19/2019. [MMA] [Entered: 06/19/2019 10:02 AM] (166) |
